News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current NEU market cap is 2.49B. The company's latest EPS is NZD 1.2335 and P/E is 15.85.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Revenue | 495k | 817k | 3.2M | 15.42M | 231.94M |
| Operating Income | -11.34M | -8.71M | -8.23M | -1.43M | 197.02M |
| Net Income | -10.82M | -9.19M | -7.79M | 184k | 157.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Total Assets | 14.41M | 24.95M | 40.06M | 43.27M | 247.97M |
| Total Liabilities | 559k | 753k | 803k | 1.68M | 42.76M |
| Total Equity | 13.85M | 24.2M | 39.25M | 41.59M | 205.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| NZD ($) | NZD ($) | NZD ($) | NZD ($) | NZD ($) | |
| Operating | -11.72M | -8.08M | -9.97M | 3.6M | 184.93M |
| Investing | -12k | -6k | -10k | -19k | -211.49M |
| Financing | 1.86M | 19.14M | 22.18M | -2k | 3.62M |
| Market Cap | 2.49B |
| Price to Earnings Ratio | 15.85 |
| Price to Sales Ratio | 10.73 |
| Price to Cash Ratio | 145.68 |
| Price to Book Ratio | 12.13 |
| Dividend Yield | - |
| Shares Outstanding | 127.35M |
| Average Volume (1 week) | 507.58k |
| Average Volume (1 Month) | 648.6k |
| 52 Week Change | 52.02% |
| 52 Week High | 25.95 |
| 52 Week Low | 10.02 |
| Spread (Intraday) | 0.45 (2.26%) |
| Company Name | Neuren Pharmaceuticals Limited |
| Address |
suite 201 auckland |
| Website | https://www.neurenpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
